https://www.selleckchem.com/pr....oducts/lotiglipron.h
The use of ACE inhibitors or angiotensin receptor blockers (AR was associated with lower sACE2 levels. In the multivariable model, higher sACE2 levels were independently associated with a higher NYHA class ≥ III (p = 0.002) and lower sACE2 levels with the use of ACE inhibitors or ARB (p = 0.001). Soluble ACE2 concentrations were significantly increased in all types of complex CHD with highest levels found in patients with NYHA class ≥ III. Moreover, a higher NYHA class ≥ III was the most significant determinant that was independen
पसंद करना
टिप्पणी
शेयर करना
